161 related articles for article (PubMed ID: 11911105)
41. Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia.
Jordan SD; Alexander E
J Pharm Pract; 2013 Jun; 26(3):257-60. PubMed ID: 22869910
[TBL] [Abstract][Full Text] [Related]
42. Pure Red Cell Aplasia After Kidney Transplantation: Parvovirus B19 Culprit or Coincidence?
Pabisiak K; Stępniewska J; Ciechanowski K
Ann Transplant; 2019 Mar; 24():123-131. PubMed ID: 30833537
[TBL] [Abstract][Full Text] [Related]
43. Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.
Pitchaipillai S; Kelsey P; Haeney M
Clin Lab Haematol; 2006 Oct; 28(5):347-50. PubMed ID: 16999728
[No Abstract] [Full Text] [Related]
44. Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses.
Stamou SC; White T; Barnett S; Boyce SW; Corso PJ; Lefrak EA
Am J Cardiol; 2006 Nov; 98(9):1223-5. PubMed ID: 17056333
[TBL] [Abstract][Full Text] [Related]
45. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
[TBL] [Abstract][Full Text] [Related]
46. A single-center experience of renal transplantation in thirteen Jehovah's Witnesses.
Kaufman DB; Sutherland DE; Fryd DS; Ascher NL; Simmons RL; Najarian JS
Transplantation; 1988 Jun; 45(6):1045-9. PubMed ID: 2837843
[TBL] [Abstract][Full Text] [Related]
47. Caring for the Jehovah's Witness Parturient.
Mason CL; Tran CK
Anesth Analg; 2015 Dec; 121(6):1564-9. PubMed ID: 26579658
[TBL] [Abstract][Full Text] [Related]
48. Parvovirus B-19 induced acute pure red cell aplasia in patients with chronic lymphocytic leukemia and neurofibromatosis type-1.
Sharma P; Singh T; Mishra D; Gaiha M
Hematology; 2006 Aug; 11(4):257-9. PubMed ID: 17178664
[TBL] [Abstract][Full Text] [Related]
49. Pure red blood cell aplasia during azathioprine therapy associated with parvovirus B19 infection.
Higashida K; Kobayashi K; Sugita K; Karakida N; Nakagomi Y; Sawanobori E; Sata Y; Aihara M; Amemiya S; Nakazawa S
Pediatr Infect Dis J; 1997 Nov; 16(11):1093-5. PubMed ID: 9384349
[No Abstract] [Full Text] [Related]
50. Simultaneous occurrence of pure red cell aplasia and papular-purpuric 'gloves and socks' syndrome in parvovirus B-19 infection.
Loukeris D; Serelis J; Aroni K; Tsakris A; Voulgarelis M
J Eur Acad Dermatol Venereol; 2005 May; 19(3):373-6. PubMed ID: 15857471
[TBL] [Abstract][Full Text] [Related]
51. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
52. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
[TBL] [Abstract][Full Text] [Related]
53. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
[TBL] [Abstract][Full Text] [Related]
54. Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection.
de Mayolo JA; Temple JD
South Med J; 1990 Dec; 83(12):1480-1. PubMed ID: 2174578
[TBL] [Abstract][Full Text] [Related]
55. Clinical strategies in the medical care of Jehovah's Witnesses.
Remmers PA; Speer AJ
Am J Med; 2006 Dec; 119(12):1013-8. PubMed ID: 17145240
[TBL] [Abstract][Full Text] [Related]
56. Management of life-threatening epistaxis in a Jehovah's Witness.
Stark RD; Coatesworth AP; Tucker AG
Int J Clin Pract; 2003; 57(1):60-1. PubMed ID: 12587946
[TBL] [Abstract][Full Text] [Related]
57. Outcomes from cardiac surgery in Jehovah's witness patients: experience over twenty-one years.
Marinakis S; Van der Linden P; Tortora R; Massaut J; Pierrakos C; Wauthy P
J Cardiothorac Surg; 2016 Apr; 11(1):67. PubMed ID: 27079663
[TBL] [Abstract][Full Text] [Related]
58. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
Ball AM; Winstead PS
Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
[TBL] [Abstract][Full Text] [Related]
59. Oncological management of pediatric cancer patients belonging to Jehovah's Witnesses: a two-institutional experience report.
Tenenbaum T; Hasan C; Kramm CM; Janssen G; Laws HJ; Wessalowski R; Bode U; Göbel U
Onkologie; 2004 Apr; 27(2):131-7. PubMed ID: 15138344
[TBL] [Abstract][Full Text] [Related]
60. Management of Jehovah's Witness patients with haematological problems.
Nash MJ; Cohen H
Blood Rev; 2004 Sep; 18(3):211-7. PubMed ID: 15183904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
